• ATKA
    Connecting Biotech Boundaries—Academia to Industry At CBB, our goal is to reshape the agricultural, chemical, nutritional, and pharmaceutical industries by combining the intellectual talents of top scientific faculty with the practical delivery of new technologies. Confidential collaborations with clients enable our laboratory to produce products and develop processes for industry, government, and academia. CBB has continued to participate in the economic development activities of The University of Iowa, by bringing biotechnology companies to The University of Iowa Research Park.
    Contact
  • CBB staff with column
    CBB's​ main laboratory concentrates on research and process development (RPD). The RPD laboratory is 13,000 Sq Ft and operates with the discipline of safe lab practices, standard operating procedures (SOPs), good documentation and well-defined protocols. The CBB RPD laboratory offers gene cloning, clonal selection, state-of-the-art fermentation, downstream purification, bioprocessing and analytical services. All work is performed by experienced, professional full-time staff with expertise in process development.
    RPD
  • In addition to research and process development laboratory, CBB provides cGMP fermentation and protein purification services for Phase 1 clinical trials. cGMP laboratory started its operations in 2007. All the critical equipment in the cGMP facilities have been qualified with Factory Acceptance Tests (FAT), IQ and OQ. Since 2007, CBB has successfully executed more than 50 campaigns. This has resulted in IND filing by a client.
    cGMP
Biotech Services state-of-the-art services on offer
Biotech Training Program learn about the program, available fellowships and training grants
Research learn about our research
Annual CBB Conference featuring world renowned speakers, representatives and attendees from industry and academia
14
patents
on glycolate oxidase (GO) technology from E. I. DuPont de Nemours and Co.
$
3.57
million
UI portion of $18 million NSF ERC grant
8
Biologics
Produced for Phase I

Events

Jul 14 4PM

UIRF Inventor Office Hours

Jul 16 1PM

Forms Submitted After IRB Approval – Modification, Continuing Review, Reportable Event Forms (REFs), and Project Close Forms

Forms Submitted After IRB Approval – Modification, Continuing Review, Reportable Event Forms (REFs), and Project Close Forms

Jul 20 2PM

Pivot Informational Session

Pivot Informational Session

Jul 21 4PM

UIRF Inventor Office Hours

Jul 23 10AM

Writing Effective NIH Grant Applications

Writing Effective NIH Grant Applications

View more events

News

Publications

Ricker E., Aljaafari H., Bader T., Hundley B., Nuxoll E. Thermal shock susceptibility and regrowth of Pseudomonas aeruginosa biofilms. Int J Hyperthermia. 2018;34(2):168-176.
Leelakanok N., Gary S., Salem A. Fabrication and Use of Poly(d,l-lactide-co-glycolide)-Based Formulations Designed for Modified Release of 5-Fluorouracil. Journal of Pharmaceutical Sciences. 2018;107:513-528.
Vance N., Gakhar L., Spies M.. Allosteric Tuning of Caspase-7: A Fragment-Based Drug Discovery Approach. Angew Chem Int Ed Engl. 2017;56(46):14443-14447.